Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer

• Hoofdauteurs: Yihang Qi (Auteur), Wenxiang Zhang (Auteur), Ray Jiang (Auteur), Olivia Xu (Auteur), Xiangyi Kong (Auteur), Lin Zhang (Auteur), Yi Fang (Auteur), Jingping Wang (Auteur), Jing Wang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT) is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple-negative breast cancer (TNBC). However, several published randomized controlled trials (RCTs) reported heterogene...